Chlamydia trachomatis
Roche Gets 510(k) Clearance, CLIA Waiver for Liat Triplex Point-of-Care STI Test
The point-of-care assay to detect and differentiate chlamydia, gonorrhea, and mycoplasma infections from a single sample will now be commercially available in the US in coming months.
Kryptos Biotechnologies Gets $1.2M Grant From RIGHT Foundation for Rapid STI Test
The funding will support optimization of a PCR-based test system and development of a 30-minute test to detect chlamydia, gonorrhea, and trichomoniasis.
The firm plans to apply more than $10 million in recent Gates Foundation grants toward regulatory submission of a rapid STI test.
Scout Nabs $1M CARB-X Award for Point-of-Care Molecular STI Test
The company plans to use the funding to demonstrate proof of concept and feasibility for a rapid test to detect chlamydia and gonorrhea.
Binx Health, Cardinal Health Strike US Distribution Deal for Point-of-Care STD Test System
The Binx io molecular diagnostics system runs a test for Chlamydia trachomatis and Neisseria gonorrhoeae that previously received a CLIA waiver.
Jan 31, 2024
Oct 4, 2021
Sep 2, 2021
Mar 30, 2021
Binx Health Chlamydia and Gonorrhea Test CLIA Waived
Sep 15, 2020
Antelope Dx Completes €9M Series B Financing Round
Aug 15, 2018